AI Vaccine Passes First Human Trial, Targets Future Viruses
Scientists at Cambridge University have successfully tested the first AI-designed vaccine in humans, a breakthrough that could protect against viruses before they even emerge. The technology aims to end the endless cycle of chasing new virus variants.